References
- Pizzo P A., Rubin M, Freifeld A, Walsh T J. The child with cancer and infection. I. Bacterial infections. J Pediatr. 1991; 119: 679–694
- Pizzo P A., Rubin M, Freifeld A, Walsh T J. The child with cancer and infection. II. Nonbacterial infections. J Pediatr. 1991; 119: 845–857
- Pinkel D. Therapy of acute lymphoid leukemia in children. Leukemia 1992; 6(2)127–131
- Aquino M V., Pappo A, Buchanan G R., Tkaczewski I, Mustafa M M. The changing epidemiology of septicemia in neutropenic children with cancer. Pediatr Infect Dis J. 1995; 14: 140–143
- Saarinen U M. Severe infections in childhood leukemia. Acta Paediatr Scand. 1984; 73: 515–522
- Perkkiö M, Hovi L, Rajantie J, et al. A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Scand J Infect Dis. 1990; 22: 209–218
- Riikonen P, Jalanko H, Hovi L, Saarinen U M. Fever and neutropenia in children with cancer: diagnostic parameters at presentation. Acta Paediatr. 1992; 81: 1–5
- Feusner J H., Hastings A. Infections in children with acute myelogenous leukemia. J Pediatr Hematol Oncol. 1995; 17: 234–247
- Bodey G P., Buckley M, Sathe Y S., Freireich E J. Quantitative relationship between circulating leucocytes and infections in patients with acute leukemia. Ann Intern Med. 1966; 64: 328–349
- Wood D J., Corbitt G. Viral infections in childhood leukemia. J Infect Dis. 1985; 152: 266–273
- Möttönen M. A prospective survey of infections in children with acute lymphoblastic leukaemia. Acta Univ Oul D. 1993; 281
- Kosmidis H V., Lusher J M., Shope T C., Ravindranath Y, Dajani A S. Infections in leukemic children: a prospective analysis. J Pediatr. 1980; 134: 28–34
- Gustafsson G, Garwicz S, Hertz H, et al. A population based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Acta Paediatr Scand. 1987; 76: 781–788
- Riikonen P, Rahiala J, Salonvaara M, Perkkiö M. Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer. Stem Cells. 1995; 13: 289–294
- Riikonen P, Saarinen U M., Mäkipernaa A, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of febrile neutropenia: a double-blind placebo controlled study in children. Pediatr Infect Dis J. 1994; 13: 197–202
- Burdach S EG, Munschenich M., Josephs W, et al. Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study. Cancer. 1995; 76: 510–516
- Pizzo P A., Hathorn J W., Hiemenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med. 1986; 315: 552–558
- Pizzo P A., Robichaud K J., Conners J R. Fever in pediatric and young adult patients in cancer, a prospective study of 1001 episodes. Medicine (Baltimore). 1982; 61: 153–165
- Riikonen P, Saarinen U M., Perkkiö M, Hovi L, Siimes M. Changing pattern of treatment policies invalidates the use of C-reactive protein level and hyponatremia as indicators of septicemia in children with malignancies. Pediatr Hematol Oncol. 1992; 9: 365–372